Trust and the acceptance of and adherence to antiretroviral therapy

Journal of Acquired Immune Deficiency Syndromes

Volumn 28, Issue 1, 2001, Pages 47-58

  Altice, Frederick L ^a   Mostashari, Farzad ^a,b   Friedland, Gerald H ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b New York City Department of Health

Author keywords

Adherence; Antiretroviral therapy; Directly observed therapy; Health beliefs; HIV AIDS; Prisoners; Social isolation; Substance abuse; Trust

Indexed keywords

ANTIRETROVIRUS AGENT; DIDANOSINE; LAMIVUDINE; RITONAVIR; SAQUINAVIR; STAVUDINE; ZALCITABINE; ZIDOVUDINE; ANTI HIV AGENTS; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CORRELATION FUNCTION; DOCTOR PATIENT RELATION; FEMALE; HEALTH STATUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; PATIENT ATTITUDE; PATIENT COMPLIANCE; PREVALENCE; PRIORITY JOURNAL; PRISONER; REGRESSION ANALYSIS; SELF REPORT; SOCIAL DESIRABILITY; SOCIAL ISOLATION; VALIDATION PROCESS; DEMOGRAPHY; GROUP PSYCHOLOGY; MULTIVARIATE ANALYSIS; PSYCHOLOGICAL ASPECT; TRUST;

ADULT; ANTI-HIV AGENTS; DEMOGRAPHY; FEMALE; HIV INFECTIONS; HUMAN; MALE; MULTIVARIATE ANALYSIS; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT COMPLIANCE; PEER GROUP; PHYSICIAN-PATIENT RELATIONS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TRUST;

EID: 0035455584     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-200109010-00008     Document Type: Article

References (77)

1. Zidovudine and the natural history of the acquired immunodeficiency syndrome
2. Survival and disease progression according to gender of patients with HIV infection. The Terry Beirn Community Programs for clinical research on AIDS
3. Variation in health service use among HIV-infected patients
4. Zidovudine therapy and health resource utilization in AIDS
5. Racial and ethnic differences in human immunodeficiency virus type 1 (HIV-1) seroprevalence among homosexual and bisexual men
6. Self-reported antiretroviral therapy in injection drug users
7. Barrier to use of free antiretroviral therapy in injection drug users
8. Update: Mortality attributable to HIV infection among persons aged 25-44 years: United States, 1994
9. Marked declines in human immunodeficiency virus-related mortality in Chicago in women, African Americans, Hispanics, young adults, injection drug users, from 1995 through 1997
10. Acceptance and adherence with antiretroviral therapy among HIV-infected women in a correctional facility
11. Adherence to antiretroviral and Pneumocystis prophylaxis in HIV disease
12. A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients: The INCAS Trial
13. Infection with the human immunodeficiency virus in prisoners: Meeting the health care challenge
14. Predictors of HIV infection among sentenced male prisoners
15. Development of the trust in physician scale: A measure to assess interpersonal trust in patient-physician relationships
16. Autonomous regulation and long-term medication adherence in adult outpatients
17. The relationship of health beliefs and psychologic mood to patient adherence to oral hygiene behavior
18. Locus of control, social support, and adherence to the diabetes regimen
19. Socially desirable response tendency as a correlate of accuracy of self-reported HIV serostatus for HIV seropositive injection drug users
20. Detecting socially desirable responding with the personality assessment inventory: The positive impression management scale and the defensiveness index
21. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection
22. Adherence and relationship to antiretroviral efficacy in the HEART (NZT) Study
23. Adherence and retention of AIDS clinical trials: A framework for research and application
24. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV outpatient study investigators
25. Addressing racial inequities in health care: Civil rights monitoring and report cards
26. Participation of African Americans in clinical research
27. Maximizing participation by black Americans in population-based diabetes research: The project DIRECT pilot experience
28. Barriers to black women's participation in cancer clinical trials
29. Evaluation of a video-supplement to informed consent: Injection drug users and preventive HIV vaccine efficacy trials
30. The politics of marginalization: The appropriation of AIDS prevention messages among injection drug users
31. Moral and social issues regarding pregnant women who use and abuse drugs
32. Establishing trust after Tuskegee
33. Utilization of on-site primary care services by HIV-seropositive and seronegative drug users in a methadone maintenance program
34. Human immunodeficiency virus infection in injection drug users: A model for primary care
35. Compliance with zidovudine therapy in patients infected with human immunodeficiency virus, type 1: A cross-sectional study in a municipal hospital clinic
36. Clinical and laboratory correlates of human immunodeficiency virus infection in a cohort of intravenous drug users from New York NY
37. Zidovudine adherence among individuals with HIV infection
38. Important elements of outpatient care: A comparison of patients' and physicians' opinions
39. Physicians' characteristics influence patients' adherence to medical treatment: Results from the Medical Outcomes Study
40. The era of adherence with HIV therapy
41. Adherence, compliance, and HAART
42. HIV/AIDS patients' perspectives on adhering to regimens containing protease inhibitors
43. A syndrome of peripheral lipodystrophy. Hyperlipidemia and insulin resistance in patients receiving protease inhibitors
44. Patients' ideas about medicines: A qualitative study in a general practice population
45. Zidovudine adherence in persons with AIDS: The relationship of patient beliefs about medication to self-termination of therapy
46. Health beliefs, personality, and adherence in hemodialysis patients: An interactional perspective
47. Adherence to antihypertensive medications across the life span
48. A preliminary study of ritonavir, an inhibitor of HIV-1 protease, to treat HIV-1 infection
49. Potential factors affecting adherence with HIV therapy
50. A comparison of BID and TID dosing of nelfinavir when given in combinations with stavudine (d4T) and lamivudine (3TC) for up to 48 weeks
51. Durability of response of efavirenz-containing regimens: Report of the post-control period results of studies with efavirenz
52. Once daily didanosine (ddI) antiretroviral therapy for HIV disease
53. Methadone effects on zidovudine disposition (AIDS Clinical Trials Group 262)
54. Nevirapine-induced opiate withdrawal among injection drug users with HIV infection receiving methadone
55. Interaction of methadone with didanosine and stavudine
56. Interactions between methadone and medications used to treat HIV infection: A review
57. Impact of directly observed therapy on outcomes on HIV clinical trials
58. Doctors withhold HIV pill regimen from some
59. Validity of patient questioning versus pill count as an assessment of compliance
60. Antiretroviral adherence and its consistency predict biologic outcomes in HIV clinical trials
61. Electronic monitoring of adherence to treatment in the preventive chemotherapy of tuberculosis
62. Pill count, self-report, and pharmacy claims data to measure medication adherence in the elderly
63. Adherence to single daily dose of aspirin in a chemoprevention trial: An evaluation of self-report and microelectronic monitoring
64. Adherence to oral tamoxifen: A comparison of patient self-report, pill counts, and microelectronic monitoring
65. Assessing medication adherence by pill count and electronic monitoring in the African America Study of Kidney disease and hypertension (AASK) pilot study
66. Critical comparison of novel and existing methods of compliance assessment during a clinical trial of an oral iron chelator
67. Determinants of adherence: The disease and the mechanics of treatment
68. Compliance with cardiovascular disease prevention strategies: A review of the research
69. Adherence to medication, diet, and activity recommendations: From assessment to maintenance
70. Transitional case management for HIV+ prisoners in Connecticut
71. A prison release program for HIV-positive women: Linking them to health services and community follow-up